相关实验视频
Updated: Jul 16, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
在怀孕21-23周时使用产前皮质类固醇
1Center for Women's Reproductive Health and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama.
产前皮质类固醇可以降低22周怀孕后出生的新生儿的死亡率. 然而,严重发病率的存活率仍然很高,需要进一步研究22周前的益处.
科学领域:
- 新生儿医学 新生儿医学
- 围产期护理 围产期护理
- 产科 产科 产科 产科 产科
背景情况:
- 在生命能力高峰期出生的新生儿面临高死亡率和严重发病风险.
- 技术的进步使得极早产婴儿的复苏成为可能,包括那些早在21周怀孕时出生的婴儿.
- 产前皮质类固醇已被证明对晚期妊娠有益,但缺乏对极度早产新生儿的试验数据.
研究的目的:
- 重新评估在怀孕24周之前分娩的产前皮质类固醇的使用情况.
- 评估当前临床实践对使用产前皮质类固醇在可食新生儿中的影响.
- 为未来的研究和临床指南提供有关产前皮质类固醇的信息.
主要方法:
- 关于产前皮质类固醇的近期观察数据的综述.
- 在怀孕22周或之后分娩的新生儿结局分析.
- 确定关于怀孕22周前分娩的研究缺口.
主要成果:
- 观察数据表明,产前皮质类固醇与22周妊娠或之后分娩的新生儿死亡率降低有关.
- 尽管死亡率降低,但在幸存者中仍然存在严重发病率很高.
- 缺乏对怀孕24周之前出生的新生儿的随机临床试验数据.
结论:
- 产前皮质类固醇显示出从怀孕22周起可食新生儿的死亡率有望降低.
- 进一步的研究至关重要,以确定22周之前的疗效,并优化时间.
- 多学科咨询对于可靠的分娩决策至关重要,将护理与患者的愿望保持一致.
更多相关视频
09:57In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Teratogenicity
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...